Mitsubishi

News Mitsubishi

• Pronota and Molecuence announce collaboration in protein biomarker discovery

  Pronota NV announced that it has entered into an agreement with Molecuence Corporation, a wholly owned subsidiary of Mitsubishi Chemical Corporation, to discover and validate protein biomarkers in stroke.  Pronota will apply its  proprietary platforms for protein biomarker discovery (MASStermind®) a more

• BioInvent signs Licensing Agreement with Mitsubishi Tanabe Pharma for the Discovery and Development of Therapeutic Antibodies

  BioInvent International AB announces that it has signed a license agreement with Mitsubishi Tanabe Pharma Corporation for the development of antibodies, up to five therapeutic targets, from BioInvent’s n-CoDeR® library. Under the terms of the agreement, Mitsubishi Tanabe will be granted access to B more

• Monoclonal antibody sales to almost double in coming years

  In 2007 total global monoclonal antibody (mAb) sales reached $26 billion and are forecast to almost double to $49 billion by 2013. While small molecule drug sales will continue to make up the majority of total market sales, the mAb market, with a compound annual growth rate (CAGR) of almost 11% will more

Publications Mitsubishi

• [News & Analysis] Solar Energy: Outlook Brightens for Plastic Solar Cells

  In early April, Mitsubishi Chemical reportedly set a new efficiency record, producing organic solar cells with a 9.2% conversion efficiency. Many researchers in the field are confident that the figure could soon top 10% and possibly reach 15%. more

Market studies Mitsubishi

• Rheumatoid Arthritis Drugs Market in Japan 2011-2015

  TechNavio’s analysts forecast the Rheumatoid Arthritis market in Japan to grow at a CAGR of 29.2 percent over the period 2011–2015. One of the key factors contributing to this market growth is the high prevalence rate of patients suffering from rheumatoid arthritis. The Rheumatoid Arthritis Drugs ma more

• Global In Vitro Diagnostics Market 2011-2015

  TechNavio's analysts forecast the Global In Vitro Diagnostics market to grow at a CAGR of 6.55 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing demand for biomarker-based tests worldwide. The Global In Vitro Diagnostics market has also be more

• End-stage Renal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2019

  Introduction GlobalData, the industry analysis specialist, has released its new report, “End-stage Renal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global End Stage Renal Disease Therapeutics market more

Websites Mitsubishi